Richard W. Paul & Associates LLC Sells 52 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Richard W. Paul & Associates LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 3.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,648 shares of the medical equipment provider’s stock after selling 52 shares during the quarter. Richard W. Paul & Associates LLC’s holdings in Intuitive Surgical were worth $556,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 0.7% in the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after buying an additional 196,316 shares during the last quarter. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.9% during the 2nd quarter. State Street Corp now owns 14,810,625 shares of the medical equipment provider’s stock valued at $5,064,345,000 after acquiring an additional 274,201 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.0% during the 1st quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock worth $1,642,287,000 after buying an additional 61,659 shares during the period. Morgan Stanley lifted its holdings in Intuitive Surgical by 29.9% during the 4th quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after buying an additional 1,351,002 shares during the period. Finally, Jennison Associates LLC lifted its stake in shares of Intuitive Surgical by 6.4% in the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after purchasing an additional 274,692 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the completion of the sale, the executive vice president now owns 189 shares of the company’s stock, valued at $69,958.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the sale, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at approximately $736,800. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock worth $95,927,097 over the last ninety days. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $3.66 during midday trading on Wednesday, hitting $386.02. 726,520 shares of the company’s stock were exchanged, compared to its average volume of 1,661,050. Intuitive Surgical, Inc. has a 52-week low of $252.04 and a 52-week high of $403.76. The stock has a 50-day moving average price of $386.82 and a two-hundred day moving average price of $335.66. The company has a market cap of $136.82 billion, a P/E ratio of 76.85, a PEG ratio of 6.13 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, topping the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The business had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. During the same period in the previous year, the business earned $0.91 earnings per share. The firm’s revenue was up 16.6% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the subject of a number of research analyst reports. Truist Financial boosted their target price on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Raymond James lifted their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Piper Sandler raised their target price on Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 24th. Royal Bank of Canada raised their target price on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Finally, Barclays raised their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $375.20.

Check Out Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.